Cerity Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
156,530
+2,684
| +2% | +$96.7K | 0.01% | 750 |
|
|
2025
Q1 | $4.79M | Buy |
153,846
+136,487
| +786% | +$4.25M | 0.01% | 744 |
|
|
2024
Q4 | $459K | Sell |
17,359
-15,537
| -47% | -$411K | ﹤0.01% | 1814 |
|
|
2024
Q3 | $931K | Buy |
32,896
+3,291
| +11% | +$93.1K | ﹤0.01% | 1430 |
|
|
2024
Q2 | $781K | Sell |
29,605
-6,822
| -19% | -$180K | ﹤0.01% | 1334 |
|
|
2024
Q1 | $1.11M | Buy |
36,427
+8,259
| +29% | +$251K | ﹤0.01% | 1230 |
|
|
2023
Q4 | $791K | Buy |
+28,168
| New | +$791K | ﹤0.01% | 1065 |
|
|
2023
Q3 | – | Sell |
-25,788
| Closed | -$793K | – | 1654 |
|
|
2023
Q2 | $793K | Buy |
25,788
+943
| +4% | +$29K | ﹤0.01% | 995 |
|
|
2023
Q1 | $893K | Buy |
24,845
+689
| +3% | +$24.8K | ﹤0.01% | 1025 |
|
|
2022
Q4 | $954K | Buy |
24,156
+177
| +0.7% | +$6.99K | 0.01% | 706 |
|
|
2022
Q3 | $963K | Buy |
23,979
+520
| +2% | +$20.9K | 0.01% | 530 |
|
|
2022
Q2 | $987K | Buy |
23,459
+2,567
| +12% | +$108K | 0.01% | 552 |
|
|
2022
Q1 | $813K | Buy |
+20,892
| New | +$813K | 0.01% | 483 |
|